OLUWATOYIN OMOLA: Open Payments
NPI 1093340267 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$141 in 7 payments from 3 companies in 2025. Trend: 2023 $89 · 2024 $63 · 2025 $141
Food & beverage: $141
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 3 | $69 |
| Otsuka America Pharmaceutical, Inc. | 3 | $49 |
| Supernus Pharmaceuticals, Inc. | 1 | $23 |
Products named: COBENFY, ABILIFY ASIMTUFII, Qelbree.
Industry payments across DC — which companies pay providers there.
